Clinical Trial Update: Ticagrelor-Based Dual Antiplatelet Therapy Duration in CABG [NA]

View source ↗

Summary

Clinical trial update exploring the duration of ticagrelor-based dual antiplatelet therapy in patients undergoing coronary artery bypass grafting; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Kexiang Liu, MD | Conditions: Coronary Artery Disease, Coronary Artery Bypass Grafting | NA | Status: NOT_YET_RECRUITING